GATINEAU, QC--(Marketwired - October 06, 2017) - The Hydropothecary Corporation ("THCX" or the "Company") (TSX VENTURE: THCX) is pleased to announce it has been awarded the Coup de Coeur Award at the inaugural Québec Employment Creators Award.

The awards are given annually to honour major job creators in Quebec and its 17 administrative regions. The awards highlight exemplary efforts made by companies in job creation, as well as their contribution to innovation, strategy and impact in sustainable jobs development within the province.

In the 2015-2016 contest period, Hydropothecary created 28 skilled jobs from entry level to corporate positions, including customer experience, order fulfillment, operations and human resources at its Gatineau-based facility. In 2016-2017, Hydropothecary created 77 jobs and its plans for expansion throughout 2018 will create another 100 jobs in Quebec.

"As Quebec's only licenced producer of cannabis, Hydropothecary is deeply honoured by the recognition this award brings to our work in building a responsible, regulated and innovative cannabis industry in Quebec and to be an economic driver in the local economy," said Hydropothecary co-founder and CEO, Sebastien St-Louis.

"We are also humbled to be included amongst such impressive companies and fellow award winners. We look forward to participating in the awards next year," he added.

Mr. St-Louis accepted the award during a gala presentation at the Quebec City Convention Centre, accompanied Mrs. Andrée St-Cyr, HR Generalist, and Mr. Pierre Killeen, Vice President, Corporate Communications and Government Relations.

About Hydropothecary Corporation (THCX)
The Hydropothecary Corporation is an authorized licensed producer and distributor of medical cannabis licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides sun grown and rigorously tested medical cannabis of uncompromising quality. Hydropothecary's branding, cannabis product offering, patient service standards and product pricing are consistent with THCX's positioning as a premium brand for a legal source for medical cannabis within this new marketplace. In addition to medical cannabis production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical cannabis, as well as the import and export of medical cannabis.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Image Available:

Contact Information:


For media inquiries, please contact:
Julie Beun
Publicist and Media Relations

Investor Relations Contact Information
Jennifer Smith
Manager of Financial Reporting and Investor Relations
1-866-438-THCX (8429)

Adam Miron